Despite complete recovery, Sepsis induced cardiomyopathy has long-term adverse effects

Written By : Jacinthlyn Sylvia |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-12-15T19:45:58+05:30 | Updated On 15 Dec 2022 9:46 PM IST

A new study published in Annals of Intensive Care suggests that sepsis-induced cardiomyopathy (SIC) may continue to have an impact on the host's system even after recovery from cardiomyopathy due to greater in-hospital mortality in patients who were hospitalized for more than 10 days and 1-month mortality.

A life-threatening organ dysfunction, such as that of the respiratory, digestive, renal, immunological, neurological, and cardiovascular systems, results from a dysregulated immune response brought on by an infection. It is debatable whether sepsis-induced cardiomyopathy affects prognosis and how it relates to death at various stages. In order to comprehend the relationship between SIC and mortality in septic patients, Yu-Min Lin and colleagues carried out a comprehensive review and meta-analysis.

From the beginning until 8 July 2021, this team identified and evaluated observational data in PubMed and Embase addressing the mortality associated with SIC among septic patients. In-hospital and one-month mortality were the outcomes. To assess the mortality risk ratio in patients with and without SIC, the random-effects model was chosen. To investigate the outcome's heterogeneity, meta-regression, subgroup, and sensitivity analyses were used.

The key findings of this study were:

1. Our findings showed that SIC was non-statistically related with higher in-hospital mortality when compared to non-SIC, but the connection was statistically significant in patients with hospital stays longer than 10 days.

2. These results included 20 trials and 4,410 septic patients.

3. Additionally, SIC was strongly linked to a greater risk of 1-month death.

4. While left ventricular dysfunction was not, among SIC patients, right ventricular dysfunction was strongly linked to an elevated 1-month death rate.

In conclusion, these results highlight the significance of early biventricular evaluation for septic patients, along with continuum treatment and monitoring for SIC patients even after recovery. Future research that includes a clearer definition of sepsis, hemodynamic measures, assessment tool factors, and outcomes is necessary to support the link between SIC and mortality.

Reference:

Lin, Y.-M., Lee, M.-C., Toh, H. S., Chang, W.-T., Chen, S.-Y., Kuo, F.-H., Tang, H.-J., Hua, Y.-M., Wei, D., Melgarejo, J., Zhang, Z.-Y., & Liao, C.-T. (2022). Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis. In Annals of Intensive Care (Vol. 12, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s13613-022-01089-3

cardiomyopathysepsisannals of intensive care

Source : Annals of Intensive Care

Jacinthlyn Sylvia

Neuroscience Masters graduate

Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751